Form 8-K MEI Pharma, Inc. For: Jun 30
Exhibit 10.1
[MEI Pharma Letterhead]
July 7, 2022
Brian G. Drazba
Dear Brian
I am confirming our agreement regarding your continued employment with MEI Pharma, Inc. (the Company).
As I notified you on June 30, 2022, your employment will continue beyond June 30, 2022. Your employment will continue in accordance with the terms of your employment agreement with the Company dated February 1, 2017, subject to adjustments in salary as approved by the Compensation Committee of the Board of Directors from time to time. You and the Company agree that the Transition and Retirement Agreement dated August 2, 2021 is hereby terminated and is of no effect.
Sincerely
/s/ Daniel P. Gold
Daniel P. Gold
Chief Executive Officer
MEI Pharma, Inc.
Agreed
/s/ Brian G. Drazba |
Brian G. Drazba |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DiCello Levitt LLP Announces Investor Lawsuit Filed Against Doximity, Inc. (NYSE: DOCS) and Lead Plaintiff Deadline
- Florida Cancer Specialists & Research Institute Presents Innovations in Patient Care at Oncology Nursing Society Global Gathering
- Quinyx's 2024 State of the Frontline Workforce Report Finds Logistics Employees Feel Undervalued, Unclear on Career Path
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!